JPRN-UMIN000007201已完成未知
Comparison of effects of cilnidipine and azelnidipine on blood pressure and urinary albumin excretion in type 2 diabetics with hypertension - Comparison of cilnidipine and azelnidipine
Juntendo University Graduate School of Medicine0 个研究点目标入组 20 人开始时间: 2012年2月2日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 30years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients with severe renal or hepatic disease, overt cardiovascular disease, and malignancy were excluded
研究者
相似试验
已完成
不适用
Comparison of effects of azelnidipine and trichlormethiazide in combination with olmesartan on blood pressure and metabolic parameters in hypertensive type 2 diabetic patientstype 2 diabetic patients with hypertensionJPRN-UMIN000005064Juntendo University Graduate School of Medicine50
已完成
不适用
Comparison of the effects of cilnidipine and benidipine on urinary excretions of albumin and type-IV collagen in Japanese hypertensive type-2 diabetic patients with nephropathy.hypertensive type-2 diabetic patients with nephropathyJPRN-UMIN000005384Akita University Garduate School of Medicine, Department of Endocrinology, Diabetes and Geriatric Medicine40
已完成
不适用
Comparison of azelnidipine and trichlormethiazide in Japanese type 2 diabetic patients with hypertension: the COAT randomized controlled trialJPRN-UMIN000006081Yokohama City Unuversity School of Medicine240
已完成
不适用
Cilnidipine versus Amlodipine Randomized Trial for Evaluation in Renal Deseasehypertensive patients with renal diseaseJPRN-UMIN000000496niversity of Tokyo Graduate School of Medicine400
已完成
不适用
Comparison of the efficacy and safety of cilnidipine 10mg/valsartan 160mg combination therapy, cilnidipine 5mg/valsartan 160mg combination therapy and valsartan 160mg monotherapy in hypertensive patients inadequately controlled with valsartan 160mg monotherapyKCT0001947Ildong pharmaceutical279